24 GOVERNMENT GRANTS
2024 | 2025 | |
| CHF 1,000 |
|
|
| Balance at January 1 | 23,519 | 19,948 |
| Reversed (included in other operating income) | (5,253) | (4,571) |
| Translation differences | 1,682 | (2,312) |
|
| |
| Balance at December 31 | 19,948 | 13,065 |
|
| |
| Thereof current | 4,987 | 4,355 |
| Thereof non-current | 14,961 | 8,710 |
In October 2020, the U.S. Department of Defense and the U.S Department of Health and Human Services awarded a government grant of USD 32.9 million to establish new production capacity in the U.S. for pipette tips, which are key components for COVID-19 testing. The amount was fully paid to the Group by the end of 2022 (CHF 26.0 million). The related production lines are reported in position property, plant and equipment and were ready for use since April 2023. Consequently, the Group has started to reverse the government grant in the consolidated statement of profit or loss in proportion to the depreciation amount.